DR high+CD45RA --tregs potentially affect the suppressive activity of the total treg pool in renal transplant patients

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Schaier, Matthias ^a   Seissler, Nicole ^a   Schmitt, Edgar ^b   Meuer, Stefan ^a   Hug, Friederike ^a   Zeier, Martin ^a   Steinborn, Andrea ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CD45 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANTIGENS, CD45; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84859059727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034208     Document Type: Article

References (33)

1. Tesi RJ, Elkhammas EA, Henry ML, Davies EA, Salazar A, et al. (1993) Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival. Transplant Proc 25: 901-902.
2. Pirsch JD, Ploeg RJ, Gange S, D'Alessandro AM, Knechtle SJ, et al. (1996) Determinants of graft survival after renal transplantation. Transplantation 61: 1581-1586.
3. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B, (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. American journal of transplantation 4: 378-383.
4. Ekberg H, Bernasconi C, Tedesco-Silva H, Vitko S, Hugo C, et al. (2009) Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. American journal of transplantation 9: 1876-1885.
5. Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, et al. (2008) Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14: 88-92.
6. Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, et al. (2007) Regulatory T cells and T cell depletion: role of immunosuppressive drugs. Journal of the American Society of Nephrology: JASN 18: 1007-1018.
7. Li XC, Turka LA, (2010) An update on regulatory T cells in transplant tolerance and rejection. Nature reviews Nephrology 6: 577-583.
8. Boros P, Bromberg JS, (2009) Human FOXP3+ regulatory T cells in transplantation. American journal of transplantation 9: 1719-1724.
9. Curotto de Lafaille MA, Lafaille JJ, (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
10. Banham AH, Powrie FM, Suri-Payer E, (2006) FOXP3+ regulatory T cells: Current controversies and future perspectives. Eur J Immunol 36: 2832-2836.
11. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. The Journal of experimental medicine 203: 1701-1711.
12. Seddiki N, Santner-Nanan B, Tangye SG, Alexander SI, Solomon M, et al. (2006) Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 107: 2830-2838.
13. Baecher-Allan C, Wolf E, Hafler DA, (2006) MHC class II expression identifies functionally distinct human regulatory T cells. Journal of immunology 176: 4622-4631.
14. Booth NJ, McQuaid AJ, Sobande T, Kissane S, Agius E, et al. (2010) Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. Journal of immunology 184: 4317-4326.
15. Haas J, Fritzsching B, Trubswetter P, Korporal M, Milkova L, et al. (2007) Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. Journal of immunology 179: 1322-1330.
16. Venken K, Hellings N, Broekmans T, Hensen K, Rummens JL, et al. (2008) Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. Journal of immunology 180: 6411-6420.
17. Lopez-Hoyos M, Segundo DS, Fernandez-Fresnedo G, Marin MJ, Gonzalez-Martin V, et al. (2009) Regulatory T cells in renal transplantation and modulation by immunosuppression. Transplantation 88: S31-39.
18. Steinborn A, Haensch GM, Mahnke K, Schmitt E, Toermer A, et al. (2008) Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol 129: 401-412.
19. Aluvihare VR, Kallikourdis M, Betz AG, (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5: 266-271.
20. Rouse BT, Sarangi PP, Suvas S, (2006) Regulatory T cells in virus infections. Immunological reviews 212: 272-286.
21. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27.
22. Beyer M, Schultze JL, (2006) Regulatory T cells in cancer. Blood 108: 804-811.
23. Stenard F, Nguyen C, Cox K, Kambham N, Umetsu DT, et al. (2009) Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 13: 70-80.
24. Louis S, Braudeau C, Giral M, Dupont A, Moizant F, et al. (2006) Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 81: 398-407.
25. Braudeau C, Racape M, Giral M, Louis S, Moreau A, et al. (2007) Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 20: 845-855.
26. Dijke IE, Korevaar SS, Caliskan K, Balk AH, Maat AP, et al. (2009) Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection. Transplantation 87: 1191-1200.
27. Kreijveld E, Koenen HJ, van Cranenbroek B, van Rijssen E, Joosten I, et al. (2008) Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus. PloS one 3: e2711.
28. Kisielewicz A, Schaier M, Schmitt E, Hug F, Haensch GM, et al. (2010) A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation. Clin Immunol 137: 209-220.
29. Baecher-Allan CM, Costantino CM, Cvetanovich GL, Ashley CW, Beriou G, et al. (2011) CD2 costimulation reveals defective activity by human CD4+CD25 hi regulatory cells in patients with multiple sclerosis. Journal of immunology 186: 3317-3326.
30. Ashley CW, Baecher-Allan C, (2009) Cutting Edge: Responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B. J Immunol 183: 4843-4847.
31. Yolcu ES, Ash S, Kaminitz A, Sagiv Y, Askenasy N, et al. (2008) Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunology and cell biology 86: 650-658.
32. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, et al. (1999) The Banff 97 working classification of renal allograft pathology. Kidney international 55: 713-723.
33. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, et al. (2010) Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. American journal of transplantation 10: 464-471.